Exothera will manufacture Meissa’s MV-012-968 vaccine candidate under CGMP regulations to supply Phase 2 clinical trials
Lilly to further investigate retatrutide for the treatment of obesity in the TRIUMPH phase 3 clinical program
Oncodesign Services and ImaginAb sign a Preclinical License and Supply Agreement
Currently there are no vaccines approved anywhere in the world for gonorrhoea, and antimicrobial resistance to existing treatments is increasing
GL0034 is a novel, investigational glucagon-like peptide 1 receptor agonist (GLP-1RA) being studied for the treatment of type 2 diabetes and obesity
This innovative product eliminates two manufacturing steps and simplifies equipment setup
Carbogen Amcis Manchester won the industry award in recognition of its efficiency improvement program implemented in response to increased demand for its products
The company will submit its comprehensive response on these observations to the USFDA
Dr. Reddy's aims to roll out its trade generics across cities and towns in India
GenWorks has scaled up its e-commerce platform in terms of building traffic
Subscribe To Our Newsletter & Stay Updated
